Clinical trial
[S,S]-Reboxetine Dose-Range Finding Trial
NCT00288652 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00288652 |
|---|---|
| Title | [S,S]-Reboxetine Dose-Range Finding Trial |
| Official title | [S,S]-Reboxetine Dose-Range Finding Trial: A 16-Week, Randomized, Double-Blind, Placebo And An Active Comparator Controlled, Multi-Center Trial Of [S,S]-Reboxetine In Patients With Postherpetic Neuralgia (PHN) |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | [S, S]-Reboxetine |
| Enrollment | 280 |
| Start date | Mar 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Feb 8, 2006 |
| Last update posted | Jun 8, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: